Episomal Reprogramming of EBV-Immortalized B Cells for iPSC Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating induced pluripotent stem cells (iPSCs) are cumbersome and inconvenient, requiring skin biopsies and labor-intensive cell culture systems, and there is a need for simpler and more accessible methods to produce patient-specific stem cells.
Innovation Solution
The method involves reprogramming Epstein-Barr virus (EBV) immortalized lymphoblastoid B cells using a feeder-free episomal approach with a cocktail of transcription factors and small molecules, allowing for the generation of iPSCs from a minimal blood sample, which can be banked for immunological or genetic analysis, and removing EBV elements to produce iPSCs essentially free of viral components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If skin biopsies and labor-intensive cell culture systems are used to generate iPSCs, then patient-specific stem cells can be produced, but the process becomes cumbersome and inconvenient
Solution Approach 1:
The patent extracts the essential function of immortalization from the complex skin biopsy process by using EBV-immortalized B cells as a starting material. This allows the reprogramming process to begin with easily accessible blood samples rather than requiring invasive skin biopsies and extensive cell culture expansion, thereby simplifying the overall procedure while maintaining the ability to produce patient-specific iPSCs
Solution Approach 2:
The patent performs preliminary immortalization of B cells using EBV before the actual reprogramming step. By pre-expanding the B cells into immortalized lymphoblastoid cell lines (LCLs) that can be banked and stored, the method eliminates the need for labor-intensive expansion during the iPSC generation process itself, making the procedure more convenient and scalable
2Ease of operation
If EBV immortalized B cells are used as starting material, then the source becomes simple and accessible, but viral elements may remain in the final iPSCs
Solution Approach 1:
The patent selectively removes EBV elements from the immortalized B cells during the reprogramming process. By using episomal vectors for reprogramming that do not integrate into the genome and by selecting against cells retaining EBV episomes, the method extracts the harmful viral components while preserving the beneficial immortalized cell source, resulting in iPSCs that are essentially free of EBV elements
Solution Approach 2:
The patent converts the potential harm of EBV persistence into a benefit by using the EBV-immortalized B cells as a convenient starting material, then systematically eliminating the viral elements. The EBV immortalization serves as a useful intermediate step that facilitates easy cell expansion and banking, while the final reprogramming step eliminates the viral contamination risk
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 3A~3B
AI summary
Methods and composition for providing induced pluripotent stem (iPS) cells are provided. For example, in certain aspects methods including reprogramming B lymphocytes transformed by episomal vectors such as Epstein-Barr virus-based vectors are described. Furthermore, the invention provides induced pluripotent stem cells essentially free of exogenous elements and having B cell immunoglobin variable region rearrangement.